Abstract
Objective
To evaluate the diagnostic accuracy of computed tomography pulmonary angiography (CTPA) and 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) for pulmonary artery (PA) masses.
Methods
Of 2889 patients with PA filling defects of PA on CTPA, 79 consecutive patients suspicious for PA malignancy who subsequently underwent 18F-FDG PET/CT were enrolled. All masses were diagnosed on the basis of pathological findings or clinical imaging follow-up. For each mass, morphological CT signs, standardized uptake value (SUVmax and SUVmean), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) on 18F-FDG PET/CT were used as diagnostic markers.
Results
Expansive growth, irregular margin, invasion, CT contrast uptake, and wall eclipse sign were strongly associated with the malignant nature of masses. The coexistence of at least 5 CT signs perfectly identified malignant masses, whereas the detection of no more than 4 CT signs did not accurately discriminate between the natures of masses. Mean SUVmax, SUVmean, MTV, and TLG values were significantly higher in malignant masses compared to those in benign masses. The diagnostic accuracy of 18F-FDG PET/CT parameters (SUV, MTV, and TLG) was excellent in detecting malignant masses. Among patients with 3 or 4 pathological CT signs, SUVmax > 3.4 significantly increased the identification of malignancies.
Conclusions
CTPA is a useful imaging modality for diagnosing PA masses, especially when at least 5 abnormal CT signs are identified. Similarly, 18F-FDG PET/CT accurately identified malignant masses and provided additional valuable information on diagnostic uncertainties after CTPA.
Similar content being viewed by others
Abbreviations
- CTPA:
-
Computed tomography pulmonary angiography
- 18F-FDG PET/CT:
-
18F-fluorodeoxyglucose positron emission tomography/computed tomography
- PA:
-
Pulmonary artery
- PTE:
-
Pulmonary thromboembolism
- PAS:
-
Pulmonary artery sarcoma
- TE:
-
Tumoral embolism
- CT:
-
Computed tomography
- MRI:
-
Magnetic resonance imaging
- SUVmax :
-
Maximum standardized uptake value
- SUVmean :
-
Mean standardized uptake value
- MTV :
-
Metabolic tumor volume
- TLG :
-
Total lesion glycolysis
- WES:
-
Wall eclipse sign
- OS:
-
Overall survival
- ROC:
-
Receiver operating characteristics
- AUC :
-
Area under the ROC curve
References
Leitman EM, McDermott S. Pulmonary arteries: imaging of pulmonary embolism and beyond. Cardiovasc Diagn Ther. 2019;9:S37–S58. https://doi.org/10.21037/cdt.2018.08.05
Srivali N, Yi ES, Ryu JH. Pulmonary artery sarcoma mimicking pulmonary embolism: a case series. QJM. 2017;110:283–6. https://doi.org/10.1093/qjmed/hcw232.
Coskun U, Sinan UY, Calpar I, Yildizeli B, Yanartas M, Filinte D, et al. Pulmonary artery sarcoma masquerading as chronic pulmonary thromboembolism. Tex Heart Inst J. 2014;41:518–522. https://doi.org/10.14503/THIJ-13-3598
Bandyopadhyay D, Panchabhai TS, Bajaj NS, Patil PD, Bunte MC. Primary pulmonary artery sarcoma: a close associate of pulmonary embolism-20-year observational analysis. J Thorac Dis. 2016;8:2592–2601. https://doi.org/10.21037/jtd.2016.08.89
Blackmon SH, Rice DC, Correa AM, Mehran R, Putnam JB, Smythe WR, et al. Management of primary pulmonary artery sarcomas. Ann Thorac Surg. 2009;87:977–84. https://doi.org/10.1016/j.athoracsur.2008.08.018.
Pomoni A, Sotiriadis C, Gay F, Jouannic AM, Qanadli SD. Percutaneous endovascular biopsy of intravascular masses: efficacy and safety in establishing pre-therapy diagnosis. Eur Radiol. 2018;28:301–7. https://doi.org/10.1007/s00330-017-4983-9.
Park JS, Chung JH, Jheon S, Choi DJ, Yoon HI, Lee JH, et al. EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism. Eur Respir J. 2011;38:1480–2. https://doi.org/10.1183/09031936.00043211.
Montani D, Jais X, Sitbon O, Dartevelle P, Simonneau G, Humbert M. EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism. Eur Respir J. 2012;39:1549–50. https://doi.org/10.1183/09031936.00008912.
Mussot S, Ghigna MR, Mercier O, Fabre D, Fadel E, Le Cesne A, et al. Retrospective institutional study of 31 patients treated for pulmonary artery sarcoma. Eur J Cardiothorac Surg. 2013;43:787–93. https://doi.org/10.1093/ejcts/ezs387.
Liu MX, Ma ZH, Jiang T, Guo XJ, Yu FF, Yang YH, et al. Differential diagnosis of pulmonary artery sarcoma and central chronic pulmonary thromboembolism using CT and MR images. Heart Lung Circ. 2018;27:819–27. https://doi.org/10.1016/j.hlc.2017.06.716.
Pu X, Song M, Huang X, Zhu G, Chen D, Gan H, et al. Clinical and radiological features of pulmonary artery sarcoma: a report of nine cases. Clin Respir J. 2018;12:1820–9. https://doi.org/10.1111/crj.12743.
Ito K, Kubota K, Morooka M, Shida Y, Hasuo K, Endo H, et al. Diagnostic usefulness of 18F-FDG PET/CT in the differentiation of pulmonary artery sarcoma and pulmonary embolism. Ann Nucl Med. 2009;23:671–6. https://doi.org/10.1007/s12149-009-0292-y.
Lee EJ, Moon SH, Choi JY, Lee KS, Choi YS, Choe YS, et al. Usefulness of fluorodeoxyglucose positron emission tomography in malignancy of pulmonary artery mimicking pulmonary embolism. ANZ J Surg. 2013;83:342–7. https://doi.org/10.1111/j.1445-2197.2012.06205.x.
Xi XY, Gao W, Gong JN, Guo XJ, Wu JY, Yang YH, et al. Value of (18)F-FDG PET/CT in differentiating malignancy of pulmonary artery from pulmonary thromboembolism: a cohort study and literature review. Int J Cardiovasc Imaging. 2019;35:1395–403. https://doi.org/10.1007/s10554-019-01553-5.
Cervilla-Munoz E, Galeano-Valle F, Del-Toro-Cervera J, Calleja-Carton E, Demelo-Rodriguez P. Differential diagnosis and treatment approach to pulmonary artery sarcoma: a case report and literature review. ERJ Open Res. 2020;6. https://doi.org/10.1183/23120541.00124-2020
Tueller C, Fischer Biner R, Minder S, Gugger M, Stoupis C, Krause TM, et al. FDG-PET in diagnostic work-up of pulmonary artery sarcomas. Eur Respir J. 2010;35:444–6. https://doi.org/10.1183/09031936.00114708.
Pan B, Wang SC, Chen ZK, Chen X. Primary pulmonary artery sarcoma with intrapulmonary metastases based on PET/CT imaging: a case report and literature review. Ann Palliat Med. 2021;10:7013–7018. https://doi.org/10.21037/apm-20-630
Gan HL, Zhang JQ, Huang XY, Yu W. The wall eclipsing sign on pulmonary artery computed tomography angiography is pathognomonic for pulmonary artery sarcoma. PLoS ONE. 2013;8:e83200. https://doi.org/10.1371/journal.pone.0083200.
Liu M, Tao XC, Zhai Z, Ma Z, Zhu L, Luo J. The filling defect of pulmonary artery, an imaging finding what we should know. Pulm Circ. 2020;10:2045894020910687. https://doi.org/10.1177/2045894020910687.
Kim C, Kim MY, Kang JW, Song JS, Lee KY, Kim SS. Pulmonary artery intimal sarcoma versus pulmonary artery thromboembolism: CT and clinical findings. Korean J Radiol. 2018;19:792–802. https://doi.org/10.3348/kjr.2018.19.4.792.
Phelps ME. PET: the merging of biology and imaging into molecular imaging. J Nucl Med. 2000;41:661–81.
Tewari P, Dixit A, Pande S, Agarwal SK, Tripathi S, Zahir Z. Obstructing granuloma in main pulmonary trunk. Ann Thorac Surg. 2020;109:e109–11. https://doi.org/10.1016/j.athoracsur.2019.05.056.
Kim YI, Kang HC, Lee HS, Choi JS, Seo KH, Kim YH, et al. Invasive pulmonary mucormycosis with concomitant lung cancer presented with massive hemoptysis by huge pseudoaneurysm of pulmonary artery. Ann Thorac Surg. 2014;98:1832–5. https://doi.org/10.1016/j.athoracsur.2013.12.051.
Chang SH, Patterson GA. Granulomatous inflammation presenting as a pulmonary artery mass. Ann Thorac Surg. 2020;109:e363–5. https://doi.org/10.1016/j.athoracsur.2019.08.039.
Lee Y, Kim HJ, Yoon H, Choi CM, Oh YM, Lee SD, et al. Clinical characteristics and treatment outcomes of primary pulmonary artery sarcoma in Korea. J Korean Med Sci. 2016;31:1755–60. https://doi.org/10.3346/jkms.2016.31.11.1755.
Acknowledgements
We would like to express our special thanks to Wei-Jie Guan and Tao Wang (State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510010, China) for their guidance in editing the manuscript. We thank all participants who took part in this study.
Funding
This project was supported by the Natural Science Foundation of Guangdong Province, China (Grant No. 2021A1515011373), and the Science and Technology Program of Guangzhou, China (Grant No. 202102010252).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
This study is approved by the ethics committee of the First Affiliated Hospital of Guangzhou Medical University (No. 2021-K-36).
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Cardiology
Cheng Hong, Peng Hou, Hai-ming Chen, and Kai-xiang Zhong are joint first authors
Take-home message
18F-FDG PET/CT integrated with CTPA identified the nature of pulmonary artery mass.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Hong, C., Hou, P., Chen, Hm. et al. Improving the imaging diagnostic strategy for pulmonary artery masses based on 18F-FDG PET/CT integrated with CTPA. Eur J Nucl Med Mol Imaging 49, 4109–4121 (2022). https://doi.org/10.1007/s00259-022-05851-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-022-05851-4